Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. (отвара нови прозор)

de Gast-Bakker DH, de Wilde RB, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, de Jonge E, Gesink-van der Veer BJ.

Извор‎: Intensive Care Med 2013;39(11):2011-9.

Индекс‎: PubMed 23995984

DOI‎: 10.1007/s00134-013-3085-7

https://www.ncbi.nlm.nih.gov/pubmed/23995984 (отвара нови прозор)

Pediatric red blood cell transfusions increase resource use. (отвара нови прозор)

Goodman AM, Pollack MM, Patel KM, Luban NL.

Извор‎: J Pediatr 2003;142(2):123-7.

Индекс‎: PubMed 12584531

DOI‎: 10.1067/mpd.2003.14

https://www.ncbi.nlm.nih.gov/pubmed/12584531 (отвара нови прозор)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (отвара нови прозор)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Извор‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Индекс‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (отвара нови прозор)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (отвара нови прозор)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Извор‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Индекс‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (отвара нови прозор)

Economic evaluation of cell salvage in pediatric surgery. (отвара нови прозор)

Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM.

Извор‎: Paediatr Anaesth 2013;23(11):1027-34.

Индекс‎: PubMed 23952976

DOI‎: 10.1111/pan.12233

https://www.ncbi.nlm.nih.gov/pubmed/23952976 (отвара нови прозор)